shanghai Longyu biotechnology Co.,Ltd
Free supplier Enterprise Certification
- Free
supplier - 4th
years
Free supplier Enterprise Certification
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Lab/Research institutions
Tel: 86-15821988213
Mobile: 86-15821988213
Tel: 86-15821988213
Fax:
URL: http://www.longyupharma.com
Province/state: Shanghai
City: Shanghai
Street: Dalian Rd 950th
MaxCard:
CAS NO.317318-70-0
best quality Cardarine(GW-501516;) reasonable price 317318-70-0 High Purity 317318-70-0
An experimental drug meant to control lipids and increase the level of HDL, or good cholesterol, in the bloodstream. A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARδ agonist. Exhibits selectivity for PPARδ compared to PPARα and PPARγ. Does not exibit any activity against other nuclear or non-nuclear receptors. Reported to increase cholesterol efflux and ABAC1 expression in macrophages, fibroblasts, and intestinal cells.
Agonist of peroxisome proliferator-activated receptor δ/β (PPARδ/β). The compound activates the nuclear receptor PPARδ downstream signalling and affects hepatic AMPK levels. It boosts the activity of the lipin 1-PPARα-PPARγ coactivator 1 (PGC-1)-α pathway and increases hepatic fatty acid oxidation. It was reported that GW 501516 prevents high-fat diet induced hypertriglyceridemia.
GW501516 is the most selective and potent PPARβ (EC50=1.1nM) agonist that has been demonstrated to be 1,000-fold more selective in comparison to existing subtypes. Studies demonstrate that GW501516 can regulate expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Additionally, GW501516 has been shown to block insulin resistance and fatty acid-induced nuclear factor-κB (NF-κB) activation.
GW 501516 is a potent and selective PPARδ agonist (EC50 = 1.2 nM). Displays <1000-fold selectivity over other PPAR subtypes. Increases ABC A1 transporter expression and induces apolipoprotein A1-mediated cholesterol efflux in vitro. Also increase serum HDL cholesterol and lowers small, dense LDL levels in obesity in vivo models.
| Catalogue Number | G931500 |
| Chemical Name | GW 501516 |
| Synonyms | 2-[2-Methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic Acid; Methyl-methyl-trifluoromethylphenyl -thiazolyl-methylsulfanyl-phenoxy-acetic Acid; GW 1516; Endurobol |
| CAS Number | 317318-70-0 |
| Alternate CAS # | 813458-54-7 |
| Molecular Formula | C??H??F?NO?S? |
| Appearance | White to Pale Yellow Solid |
| Melting Point | 134 - 144°C |
| Molecular Weight | 453.50 |
| Storage | Refrigerator |
| Solubility | DMSO (Slightly), Methanol (Slightly) |
| Stability | No Data available |
| Category | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| Applications | An experimental drug meant to control lipids and increase the level of HDL, or good cholesterol, in the bloodstream. A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARδ agonist. Exhibits selectivity for PPARδ compared to PPARα and PPARγ. Does not exibit any activity against other nuclear or non-nuclear receptors. Reported to increase cholesterol efflux and ABAC1 expression in macrophages, fibroblasts, and intestinal cells. GW 501516 has been found to enhance endurance in mice without any training. |